All Stories

  1. Pregnancy vs. Postpartum Breast Cancer: Distinct Tumor Biology and Survival Trends in a Contemporary Cohort
  2. Mediterranean diet adherence among women attending mobile breast cancer prevention program: results of a cross-sectional study in Italy
  3. Meaning, Identity, and Practice in Nipple-Areola Complex Tattooing Among Breast Cancer Survivors: A Scoping Review With a Data Mining Approach
  4. Personalized Surgical Strategies in Breast Cancer: Preliminary Evaluation of the Alexis® Retractor for Reducing Postoperative Complications and Improving Operative Efficiency
  5. A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials
  6. Can the Use of Closed Incision Negative Pressure Wound Therapy in Immediate Prepectoral Breast Reconstruction With Polyurethane-coated Implants Reduce the Rate of Early Complications? : A Comparative Study
  7. Current Evidence on Surgical Approach to Local Recurrence After Nipple-Sparing Mastectomy: Is It Time to Classify in Order to Decide Better?
  8. Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer
  9. Long term outcomes of breast primary sarcomas and malignant phyllodes tumors: 20 years observational analysis of the BEAM∗ study group. (∗the breast European association for mesenchymal tumors)
  10. Surgical Management of Ipsilateral Breast Cancer Recurrence After Conservative Mastectomy and Prepectoral Breast Reconstruction: Exploring the Role of Wide Local Excision
  11. Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)
  12. Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study
  13. Re-Excision After Positive Margins in Breast-Conserving Surgery: Can a Risk-Based Strategy Avoid Unnecessary Surgery?
  14. The e-BRAVE study: A prospective web-based cohort and biobank of women carriers of BRCA mutations
  15. Prepectoral Breast Reconstruction: Early and Long-term Complications and Outcomes of Total Coverage ADM and Implants vs Polyurethane-Coated Implants Without Use of Acellular Dermal Matrix
  16. Immediate Breast Reconstruction with Prepectoral Polyurethane-Covered Implant After Conservative Mastectomy in Large and Ptotic Breasts
  17. Use of membrane lipidome, body weight, and composition in stratification of early breast cancer patients
  18. Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective Study
  19. Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study
  20. Abstract PS18-05: Clinical Management and Oncological Outcomes of Pure Pleomorphic and Florid Lobular Carcinoma in Situ of the Breast: Results from the MultiLCIS Study
  21. Abstract P1-11-18: Detrimental effect on survival of neoadjuvant (NACT) versus adjuvant (ACT) chemotherapy in stage II-III hormone receptor-positive & HER2-neg (HR+/HER2-) breast cancer: A propensity score-matched (PSM) analysis of a retrospective ...
  22. Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort
  23. Personalizing Neoadjuvant Chemotherapy: The Impact of BRCA Variants on Pathologic Complete Response in Luminal B Breast Cancer
  24. Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors
  25. Oxidized regenerated cellulose in thoracic surgery: potential game-changer or hidden danger?
  26. Redefining conservative mastectomy: the evolution of surgical techniques
  27. Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria
  28. Personalizing Breast Cancer Surgery: Harnessing the Power of ROME (Radiological and Oncoplastic Multidisciplinary Evaluation)
  29. Oncological Safety of Prepectoral Implant-Based Breast Reconstruction After Conservative Mastectomy: Insights from 842 Consecutive Breast Cancer Patients
  30. Advancing Breast Cancer Care in Patients Aged 80 and Above: A Personalized and Multidisciplinary Management to Better Outcomes
  31. Surgery of the Primary Tumor in de novo Metastatic Breast Cancer: A Palliative Approach or a Potential Survival Game-Changer?
  32. Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy
  33. The LYMPH trial: comparing microsurgical with conservative treatment for chronic breast cancer-associated lymphoedema – study protocol of a pragmatic randomised international multicentre superiority trial
  34. Are 1 mm margins necessary after breast-conserving surgery for invasive cancer? A critical look at the proposed change
  35. Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives
  36. Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan
  37. Positive margins after breast-conserving surgery: is it possible to hang up the scalpel in the era of precision medicine?
  38. Navigating the Uncertainty of B3 Breast Lesions: Diagnostic Challenges and Evolving Management Strategies
  39. Reevaluating the promise: is primary tumor surgery really the key to survival or just a misinterpretation in de novo stage IV breast cancer?
  40. Primary tumor surgery in de novo metastatic breast cancer: Game-changer or misinterpretation?
  41. Assessing Malignant Risk in B3 Breast Lesions: Clinical Insights and Implications
  42. Advancing Breast Cancer Care in Octogenarians: A Personalized and Multidisciplinary Management to Better Outcomes
  43. Personalizing Breast Cancer Surgery: Harnessing the Power of ROME (Radiological and Oncoplastic Multidisciplinary Evaluation)
  44. The role of body composition in neurological and hematologic toxicity in a retrospective analysis of 120 breast cancer patients undergoing neoadjuvant chemotherapy: the COMBOTOX study
  45. Navigating the Uncertainty of B3 Breast Lesions: Diagnostic Challenges and Evolving Management Strategies
  46. 255P Predicting early recurrence in breast cancer patients undergoing neo-adjuvant chemotherapy through MRI-radiomics analysis
  47. Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2
  48. Fat Grafting and Prepectoral Prosthetic Reconstruction with Polyurethane-Covered Implants: Protective Role against Adjuvant Radiotherapy
  49. Outcomes of Radiotherapy in Oligoprogressive Breast Cancer
  50. Young Women with Early-Stage Breast Cancer Treated with Upfront Surgery: Overview of Oncological Outcomes
  51. Long-Term Safety of Level II Oncoplastic Surgery after Neoadjuvant Treatment for Locally Advanced Breast Cancer: A 20-Year Experience
  52. Trastuzumab Deruxtecan in brain metastases from breast cancer: outcome analysis of real life population
  53. Simultaneous Integrated Boost (Sib) Intensity-Modulated Radiotherapy for Treatment of Bone Metastases: Analysis of a Breast Cancer Cohort
  54. De-Escalation of Surgical Treatment after Neoadjuvant Chemotherapy in Breast Cancer Patients
  55. The role of body composition in neurological and hematologic toxicity in breast cancer patients undergoing neoadjuvant chemotherapy. The COMBOTOX study
  56. Abstract PO2-01-14: Development of Artificial Intelligence-based Machine Learning Models for Predicting Survival In Hormone-Receptor-Positive/HER2-Negative Early Breast Cancer undergoing Neoadjuvant Chemotherapy
  57. Abstract PO4-01-02: High throughput analysis in HER2 positive locally advanced breast cancer: pCR and mutational status
  58. 133P Clinico-pathological predictors of outcome in the (neo)adjuvant setting of luminal/HER2-negative invasive lobular breast cancer (ILC)
  59. Preventing Bone Loss in Breast Cancer Patients: Designing a Personalized Clinical Pathway in a Large-Volume Research Hospital
  60. Accessible Machine Learning and Deep Learning Models Predict Response and Survival in Early Stage Hormone Receptor-Positive/HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
  61. Preventing Bone Loss in Breast Cancer Patients: Designing a Personalized Clinical Pathway in a Large-Volume Research Hospital
  62. Expanding the use of Oncoplastic Surgery in Invasive Lobular Breast Cancer: long-term results of 476 patients treated with three different surgical approaches
  63. Inflammatory breast cancer: A clinical syndrome requiring multidisciplinary management
  64. Conserving surgery in inflammatory breast cancer after neoadjuvant chemotherapy in patients with clinical complete response: the ConSIBreC randomized controlled trial
  65. The LYMPH Trial - Comparing Microsurgical with Conservative Treatment of Chronic Breast Cancer Associated Lymphedema: Study Protocol of a Pragmatic Randomized International Multicentre Superiority Trial
  66. Editorial: Methods in breast cancer
  67. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: a scoring system to predict the risk of upgrade to malignancy
  68. Use of Oxidized Regenerated Cellulose in Patients with Lung Cancer: A Biomaterial to Handle with Caution!
  69. Inflammatory breast cancer: is conservative surgery possible?
  70. 276P Development and external validation of an artificial intelligence (AI)-based machine learning model (ML) for predicting pathological complete response (pCR) in hormone-receptor (HoR)-positive/HER2-negative early breast cancer (EBC) undergoing neoa...
  71. Recommendations for an Effective and Safe Extreme Oncoplastic Breast Surgery Combining Multiple Techniques
  72. Commentary: A lymph node mediastinal foreign body reaction mimicking nodal metastasis: a case series
  73. An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy
  74. Magnetic seed versus skin tattoo localization of non-palpable breast lesions: a single institution cohort study
  75. Tibolone and Breast Tissue: a Review
  76. Precision surgery for breast cancer: current trends and future perspectives
  77. Artificial intelligence (AI) –based machine learning models (ML) for predicting pathological complete response (pCR) in patients with hormone receptor (HoR) –positive/HER2-negative early breast cancer (EBC) undergoing neoadjuvant chemotherapy (NCT): A ...
  78. Local Treatment of Triple-Negative Breast Cancer: Is Mastectomy Superior to Breast-Conserving Surgery?
  79. 138P Activity and efficacy of neoadjuvant chemotherapy (NACT) in luminal-HER2-negative early breast cancer (EBC) according to HER2 score (low vs score 0): A retrospective study
  80. Endocrine Disruptors in Food, Estrobolome and Breast Cancer
  81. Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting
  82. Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
  83. P199 Management and Outcomes of Very Young Women (≤35 Years) with Breast Cancer treated in a single Institution
  84. P231 Prepectoral versus subpectoral single stage breast reconstruction after conservative mastectomy for breast cancer: surgical and oncological outcomes
  85. Selective Axillary Dissection after Neoadjuvant Chemotherapy in Patients with Lymph-Node-Positive Breast Cancer (CLYP Study): The Radio-Guided Occult Lesion Localization Technique for Biopsy-Proven Metastatic Lymph Nodes
  86. Endocrine Disruptors in Food, Estrobolome and Breast Cancer
  87. Upfront surgery or neoadjuvant chemotherapy in young women with breast cancer: results of a retrospective cohort study
  88. Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
  89. The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer
  90. The Ultrasound Evolution of Lateral Thoracic Perforator Flaps Design and Harvest for Partial and Total Breast Reconstruction
  91. Racial and ethnic disparities in breast cancer survival: critical appraisal of the data emerging from the randomized TAILORx
  92. Paget’s disease of the breast: Our 20 years’ experience
  93. Oncoplastic Breast Surgery versus Conservative Mastectomy in the Management of Large Ductal Carcinoma In Situ (DCIS): Surgical, Oncological, and Patient-Reported Outcomes
  94. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries
  95. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer
  96. BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making
  97. Prepectoral vs. Submuscular Immediate Breast Reconstruction in Patients Undergoing Mastectomy after Neoadjuvant Chemotherapy: Our Early Experience
  98. Lymphatic Tissue Transfer: Ultrasound-Guided Description and Preoperative Planning of Vascularised Lymph Nodes, Lymphatic Units, and Lymphatic Vessels Transfers
  99. Lifestyle counselling and access to integrative treatments in Italian breast centres: Senonetwork national survey
  100. Magnetic Seed versus skin tattoo localization of non-palpable breast lesions: a single institution cohort study
  101. Editorial: Update of Current Evidences in Breast Cancer Surgery
  102. Diagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral Mammography
  103. Endocrine Disruptors in Food, Estrobolome and Breast Cancer
  104. A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer
  105. 123P Paget’s disease of the breast: Our 20-year experience
  106. 191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis
  107. Innovations in the Integrated Management of Breast Cancer
  108. Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis
  109. Vitamin D and Histological Features of Breast Cancer: Preliminary Data from an Observational Retrospective Italian Study
  110. Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience
  111. Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial
  112. Update of Current Evidences in Breast Cancer Surgery
  113. Nipple sparing mastectomy with prepectoral immediate prosthetic reconstruction without acellular dermal matrices: a single center experience
  114. Surgical treatment of breast cancer
  115. Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis
  116. Surgical management of BRCA pathogenic variant carriers with breast cancer: a recent literature review and current state of the art
  117. Techniques for sentinel node biopsy in breast cancer
  118. Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials
  119. Improving Results in Oncoplastic Surgery
  120. SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study
  121. Let-7a-5p, miR-100-5p, miR-101-3p, and miR-199a-3p Hyperexpression as Potential Predictive Biomarkers in Early Breast Cancer Patients
  122. Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study
  123. Breast conserving surgery using oxidized regenerated cellulose as filling biomaterial: recommendations to improve clinical outcomes
  124. Histopathological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) as Predictive Biomarker for Hormone Receptors Status, Proliferative Activity and Clinical Outcome in Her-2 Positive Breast Cancer
  125. Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
  126. How will artificial intelligence impact breast cancer research efficiency?
  127. Decision-making and technical skills to prevent local recurrence after mastectomy for pure ductal carcinoma in situ
  128. Oligometastatic Breast Cancer: How to Manage It?
  129. Letter to the Editor: critical appraisal to optimize clinical and economic impact of oxidized regenerated cellulose in surgical practice
  130. De-escalation of axillary treatment in neoadjuvant setting: recommendations for a successful work
  131. Axillary Nodal Metastases from Carcinoma of Unknown Primary (CUPAx): Role of Contrast-Enhanced Spectral Mammography (CESM) in Detecting Occult Breast Cancer
  132. Breast Cancer-Related Lymphedema: Recent Updates on Diagnosis, Severity and Available Treatments
  133. Hormone Receptor Expression Variations in Normal Breast Tissue: Preliminary Results of a Prospective Observational Study
  134. Immediate implant-based breast reconstruction with acellular dermal matrix after conservative mastectomy: can a more effective alternative be used in the near future?
  135. Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes
  136. Melanocyte Colonization and Pigmentation of Breast Carcinoma: Description of Two Pathological Cases and Review of Literature
  137. Conventional CT versus Dedicated CT Angiography in DIEP Flap Planning: A Feasibility Study
  138. Myofibroblastoma of the breast: two case reports and literature review
  139. Development of a Digital Research Assistant for the Management of Patients’ Enrollment in Oncology Clinical Trials within a Research Hospital
  140. Different Impact of Definitions of Sarcopenia in Defining Frailty Status in a Population of Older Women with Early Breast Cancer
  141. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
  142. Timing of surgery following SARS-CoV-2 infection
  143. Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis
  144. Sentinel Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Preliminary Experience with Clinically Node Negative Patients after Systemic Treatment
  145. Immediate Prosthetic Breast Reconstruction after Nipple-Sparing Mastectomy: Traditional Subpectoral Technique versus Direct-to-Implant Prepectoral Reconstruction without Acellular Dermal Matrix
  146. The Assisi Think Tank Meeting Breast Large Database for Standardized Data Collection in Breast Cancer—ATTM.BLADE
  147. The Key Role of Human Microbiota in Breast Cancer
  148. Image-Guided Localization Techniques for Surgical Excision of Non-Palpable Breast Lesions: An Overview of Current Literature and Our Experience with Preoperative Skin Tattoo
  149. Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach
  150. Decision-Making Skills and Performance of Standardized Tasks Can Optimize Total Operating Time in Breast Cancer Patients Undergoing Mastectomy
  151. GENERATOR Breast DataMart—The Novel Breast Cancer Data Discovery System for Research and Monitoring: Preliminary Results and Future Perspectives
  152. Acellular dermal matrix as filler in breast-conserving surgery: warnings for a careful use
  153. Racial and ethnic disparities in breast cancer survival: critical appraisal of the data emerging from the randomized TAILORx
  154. Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
  155. Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series
  156. PO-0982: Preliminary analysis of radiotherapy role on PFS-2 in oligoprogressive breast cancer
  157. Mastectomy with immediate breast reconstruction during “phase 1” COVID‐19 emergency: An Italian experience
  158. Evidence-based medicine is a valuable tool for a successful decision-making on risk-reducing bilateral mastectomy
  159. Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis
  160. Compliance with Specific Recommendations and Tasks Reduces Nipple Necrosis Rates in Prepectoral Implant-Based Reconstruction After Nipple-Sparing Mastectomy
  161. 285P Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis
  162. Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians
  163. Performance of standardized tasks and evidence-based surgery may increase the chance of success in breast conserving treatment
  164. The impact of the COVID‐19 pandemic on breast cancer patients awaiting surgery: Observational survey in an Italian University hospital
  165. Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review
  166. Low‐grade myofibroblastic sarcoma of the breast
  167. Transaxillary Nipple-Sparing Mastectomy and Direct-to-Implant Breast Reconstruction Using a Simplified Endoscopic Approach: Indications, Cosmetic Outcomes and Technical Refinements
  168. Actualities on Diagnosis, Targeting and Treating Bone Metastases in Breast Cancer with Radiotherapy and New Drugs
  169. Evidence-based surgery to realize a successful extreme oncoplastic breast conservation
  170. OlympiAD trial: moving to a next level of treatment for patients with BRCA mutation and her2-negative metastatic breast cancer
  171. Evidence-based nipple-sparing mastectomy in patients with higher body mass index: Recommendations for a successful standardized surgery
  172. Oncoplastic Breast-Conserving Surgery
  173. Oral contraceptives and breast cancer risk: An overestimated risk?
  174. Poor efficacy of palbociclib in second‐line treatment of metastatic lobular breast cancer in a case series: Use before or never more?
  175. Menopausal hormone therapy: what should be kept in mind for a personalized choice in a shared decision-making
  176. A Rare Case of Nipple–Areolar Complex Partial Necrosis following Micropigmentation
  177. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendations to optimize the performance
  178. Results obtained with level II oncoplastic surgery spanning 20 years of breast cancer treatment: Do we really need further demonstration of reliability?
  179. Nipple‐sparing mastectomy combined with endoscopic immediate reconstruction via axillary incision for breast cancer: A preliminary experience of an innovative technique
  180. Hormone replacement therapy
  181. Oncoplastic Breast-Conserving Surgery
  182. Oncoplastic Breast Reconstruction in Conservation Surgery: Steps to Follow for a Successful Work
  183. Contralateral prophylactic mastectomy: What should not be forgotten to improve communication between clinicians and patients!
  184. Internal surgical use of biodegradable carbohydrate polymers. Warning for a conscious and proper use of oxidized regenerated cellulose
  185. Personalized medicine in breast cancer: a step forward
  186. Comment on “Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer”
  187. Breast-conservation Therapy After Neoadjuvant Chemotherapy
  188. Re: Oncoplastic partial breast reconstruction improves patient satisfaction and aesthetic outcome for central breast tumours
  189. Steps to follow in oncoplastic breast surgery to optimise oncological and cosmetic outcome
  190. Transaxillary Nipple-Sparing Mastectomy, Lymphadenectomy and Direct-to-Implant Submuscular Breast Reconstruction Using Endoscopic Technique
  191. Bilateral risk‐reducing mastectomy in BRCA mutation carriers: A difficult decision‐making
  192. What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers
  193. Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome
  194. Extreme oncoplastic breast conserving surgery: Is surgical dexterity all that is need?
  195. EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy
  196. The role of radiotherapy (RT) in the treatment of Adenoid Cystic Carcinoma of the Breast: case report of RT retreatment and literature review
  197. “Warning” to postoperative complications when using hemostatic agents!
  198. Abstract P1-11-03: Impact of scalp cooling device (SCD) in preventing alopecia in women undergoing chemotherapy for breast cancer
  199. What surgical oncology providers and women with sporadic breast cancer should not forget in the decision-making about contralateral prophylactic mastectomy!
  200. Contralateral prophylactic mastectomy: Warnings for a difficult decision to make with caution!
  201. The modern concept of breast conserving surgery
  202. Update of current evidences in breast cancer multidisciplinary management
  203. New techniques for sentinel node biopsy in breast cancer
  204. Current weaknesses of breast conserving strategies after neoadjuvant chemotherapy in breast cancer treatment
  205. Diagnosis and management of breast lymphoma: a single-institution retrospective analysis
  206. Taking one step backward to take two steps forward: the importance of breast tumor phenotype in MRI-based prediction of response
  207. Current controversies in the treatment of ductal carcinoma in situ of the breast
  208. New challenges in multimodal workout of locally advanced breast cancer
  209. Metastatic giant malignant phyllodes tumor of the breast
  210. Giant Malignant Phyllodes Tumor of the Breast: A Case Report
  211. Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer
  212. Mastectomy in precision oncology era: myth or reality?
  213. The Venous Lymph Node Flap: Concepts, Experimental Evidence, and Potential Clinical Implications
  214. Magnetic resonance imaging appearance of oxidized regenerated cellulose in breast cancer surgery
  215. EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series
  216. Penile cancer metastasizing to the breast: a case report
  217. Septum-based cervical lymph-node free flap in rat: a new model
  218. YB-1 in breast cancer. Our laboratory data
  219. Inverted T Skin-Reducing Mastectomy and One-Stage Immediate Implant Reconstruction
  220. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
  221. Mammographic and Ultrasonographic Findings of Oxidized Regenerated Cellulose in Breast Cancer Surgery: A 5-Year Experience
  222. Oxidized regenerated cellulose in breast surgery: experimental model
  223. AMAROS Study: Overall Survival in Breast Cancer Subtypes
  224. Contralateral Breast Symmetrisation in Immediate Prosthetic Breast Reconstruction after Unilateral Nipple-Sparing Mastectomy: The Tailored Reduction/Augmentation Mammaplasty
  225. New trends in breast cancer surgery: a therapeutic approach increasingly efficacy and respectful of the patient
  226. Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: Final results of a prospective phase II study
  227. Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment
  228. Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors
  229. Oncoplastic Breast Surgery with Oxidized Regenerated Cellulose: Appraisals Based on Five-year Experience
  230. The Breast Unit and the Organization of Health Care
  231. Prognostic Role of Human Epidermal Growth Factor Receptor 2 Status in Premenopausal Early Breast Cancer Treated With Adjuvant Tamoxifen
  232. Inverted-T Skin-Reducing Mastectomy with Immediate Implant Reconstruction Using the Submuscular-Subfascial Pocket
  233. EP-0988 COMPARISON OF TWO RADIATION BOOST TECHNIQUES IN PATIENTS UNDERGOING NEOADJUVANT TREATMENT FOR BREAST CANCER
  234. 488 Comparison Between Two Radiation Planning Techniques for the Breast Boost in Patients Who Underwent Neoadjuvant Chemotherapy for Breast Cancer
  235. 466 Benefit of Different Radiation Boost Dose Based on Surgical Margins – Single-institution Experience on 2 173 Patients Treated with Radiotherapy After Breast-conserving Surgery
  236. A Feasibility Study of Neo-Adjuvant Low-Dose Fractionated Radiotherapy with Two Different Concurrent Anthracycline-Docetaxel Schedules in Stage IIA/B-IIIA Breast Cancer
  237. 776 poster THE PRELIMINARY RESULTS OF PHASE II STUDY: NEOADJUVANT CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR BREAST CANCER
  238. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness
  239. 345 Sentinel lymph node biopsy after neoadjuvant chemotherapy in locally advanced breast cancer patients: feasibility, accuracy and disease upstaging
  240. Early onset lactating adenoma and the role of breast MRI: a case report
  241. Accessory nipple reconstruction following a central quadrantectomy: a case report
  242. Breast MRI in a Case of “Early Onset” Lactating Adenoma
  243. Congenital Tumors of the Retrorectal Space in the Adult: Report of Two Cases and Review of the Literature
  244. Solid breast mass characterisation: use of the sonographic BI-RADS classification
  245. Oncoplastic Techniques in the Conservative Surgical Treatment of Breast Cancer: An Overview
  246. Gastro-intestinal symptoms as clinical manifestation of peritoneal and retroperitoneal spread of an invasive lobular breast cancer: report of a case and review of the literature
  247. Characterization of Solid Breast Masses
  248. ERRATA
  249. Conservative Treatment with Nipple-Areolar Resection for Subareolar Breast Cancer
  250. Synchronous Bilateral Breast Carcinoma in a 50-Year-Old Man with 45,X/46,XY Mosaic Karyotype: Report of a Case
  251. Synchronous Bilateral Paget's Disease of the Nipple Associated with Bilateral Breast Carcinoma
  252. Phyllodes Tumor of the Breast: Magnetic Resonance Imaging Findings and Surgical Treatment
  253. Oncoplastic techniques in the conservative surgical treatment of Breast Cancer
  254. Book Review